I am disappointed that they didn't mention the trial at all, in fact I am concerned when I read today
" Following the receipt of the option related money the company has $5.5m to be applied to continue the development of our Her-2 focused clinical candidate, HER-Vaxx, plus our broader mimotope platform and arginine modulator program. "
...." to continue the development of our Her-2 focused clinical candidate " means they may have canceled the trials to get a newer version out. The vax was produced last year and shipped in August. Not sure about the shelf life but it may have expired by now.
More and more Meeerkat's comments do the trick in my mind planting and increasing doubts.
The website still got the trials on "recruiting" in Thailand but who knows what's really going on.
GLTA
Ann: Appendix 4C - quarterly and Commentry Q3, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
-0.002(4.26%) |
Mkt cap ! $334.7M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.8¢ | 4.4¢ | $890.8K | 19.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 176601 | 4.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 877572 | 7 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |